Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion

PURPOSE: The purpose of this study was to evaluate the efficacy of the combination therapy of intravitreal aflibercept 2 mg (Eylea(®)) and a sustained-release dexamethasone 0.7 mg intravitreal implant (Ozurdex(®)) versus dexamethasone alone in providing better visual acuity in eyes with macular edem...

Descripción completa

Detalles Bibliográficos
Autores principales: Harb, Walid, Chidiac, Georgio, Harb, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270014/
https://www.ncbi.nlm.nih.gov/pubmed/34321818
http://dx.doi.org/10.4103/meajo.MEAJO_297_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270014/
https://www.ncbi.nlm.nih.gov/pubmed/34321818
http://dx.doi.org/10.4103/meajo.MEAJO_297_19

Ejemplares similares